<DOC>
	<DOC>NCT00042692</DOC>
	<brief_summary>The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.</brief_summary>
	<brief_title>Catechol Thioethers in Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>First diagnosis of Parkinson's disease.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>catechol thioethers</keyword>
	<keyword>Parkinson's disease</keyword>
	<keyword>neurodegenerative disease</keyword>
</DOC>